Veraxa Biotech files initial beneficial ownership statement for CFO Raju Sudir Willener
VRXA•Form 3 filing for CFO
- Veraxa Biotech filed an initial Form 3 disclosing Chief Financial Officer Raju Sudir Willener as a reporting insider as of Sept. 1, 2026.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Veraxa Biotech AG published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001829126-26-010085), on September 14, 2026, and is solely responsible for the information contained therein.




